General information
All starting materials were purchased from Sigma-Aldrich/Chem-Impex and used further without any additional purification. Analytical thin-layer chromatography (TLC) was performed using aluminum plates precoated with silica gel (0.25 mm, 60 Å pore-size) impregnated with a fluorescent indicator (254 nm). Visualization on TLC was achieved by the use of UV light (254 nm), treatment with 10% ninhydrin in ethanol or stained with iodine vapours. Flash column chromatography was undertaken on silica gel (230-400 mesh). Proton nuclear magnetic resonance spectra ( 1 H NMR) were recorded on AVANCE III 400 Bruker (400 MHz). Proton chemical shifts are expressed in parts per million (ppm, δ scale) and are referenced to residual protium in the NMR solvent (CD 3 OD, δ 3.31). The following abbreviations were used to describe peak patterns when appropriate: br = broad, s = singlet, d
= doublet, t = triplet, q = quadruplet, m = multiplet. Coupling constants, J, were reported in Hertz unit (Hz) . Carbon 13 nuclear magnetic resonance spectroscopy ( 13 C NMR) was recorded on AVANCE III 400 Bruker (100 MHz) and was fully decoupled by broad band decoupling. Chemical shifts were reported in ppm referenced to the centre line at a 49.0 ppm of CD 3 OD. High resolution mass spectra were taken with MAXIS-Bruker using ESI-TOF method. All final peptides were checked for their homogeneity on the Shimadzu Prominence A-8 model using a Supelcosil TM LC-18 column (25 cm × 4.6 mm, 5 µm). The peptides were analyzed by using solvent system of CH 3 CN-H 2 O-0.1% CF 3 CO 2 H in two different gradients system: (i) method A: 40 min gradient, 5-85% CH 3 CN-H 2 O-0.1% CF 3 CO 2 H at 220 nm for Series 1-2; (ii) method B: 60 min gradient, 5-95% CH 3 CN-H 2 O-0.1% CF 3 CO 2 H at 220 nm for Series 3-4. All MW-irradiation reactions were carried out on a CEM Discover® microwave reactor.
Experimental procedure

General experimental procedure for of N--Boc-2-aryl-L-histidines (3a-g)
To a solution of N--trifluoroacetyl-L-histidine methyl ester (1.89 mmol, 1.0 equiv) in dichloromethane (CH 2 Cl 2 , 5 mL), trifluoroacetic acid (TFA, 2.83 mmol, 1.5 equiv) was added. After 5 min, a solution of silver nitrate (0.37 mmol, 0.2 equiv) in water (5 mL) was added, followed by arylboronic acid (3.77 mmol, 2 equiv). Ammonium persulfate (3.77 mmol, 2.0 equiv) was then added in one portion and the solution was stirred vigorously at ambient temperature for 10-18 h, and progress of the reaction was monitored by thin-layer chromatography analysis. Upon the completion of reaction, the pH of the reaction mixture was adjusted to 11-12 by the addition of aqueous ammonia solution. The residual CH 2 Cl 2 was evaporated followed by dilution with water, and extraction of the reaction mixture with ethyl acetate (3 × 30 mL). The organic layer was washed with brine. The resulting organic solution was dried over sodium sulfate, and filtered. The filtrate was concentrated, and the residue was purified by flash column chromatography to provide N--trifluoroacetyl-2-aryl-L-histidine methyl ester. 2-Aryl-L-histidine (13a-g) were synthesized by refluxing a solution of N--trifluoroacetyl-2-aryl-L-histidine methyl ester in 6N HCl for 16-24 h. 2-Aryl-L-histidine (13a-g, 1 mmol) was suspended in a mixture of water-dioxane (2:3) . A solution of 4N NaOH was added and pH of the reaction mixture was adjusted to 12. After that di-tert-butyl dicarbonate (2 mmol) was added to the reaction mixture in one portion. After 10 min, pH was again adjusted to 12 and di-tert-butyl dicarbonate (2 mmol) was added in second portion. Reaction was allowed to stir at ambient temperature for 12 h. Solvent was removed under reduced pressure and methanol (10 mL) was added to the viscous residue. The resulting solution was stirred at ambient temperature for additional 12 h. The complete removal of solvent followed by treatment of resulting N--Boc-His(2-aryl)-O -Na + with saturated aqueous solution of KHSO 4 to pH 3.75 generated the free N--Boc-2-aryl-L-histidine. The solvent was removed under reduced pressure and the resulting residue was extraction with t-butanol (4 × 50 mL).
The evaporation of the solvent under reduced pressure afforded 3a-g. 1
General experimental procedure for dipeptides (4a-g and 7a-g)
In a 10 mL MW vial equipped with a magnetic stir bar, amino acid Arg-NHBzl/OMe (1 mmol) were added followed by DIEA (3 mmol). Boc-2-aryl-His-OH (1.2 mmol) was added followed by DIC (1.2 mmol) and HONB (1.2 mmol). Mixture was subjected to MWirradiation (CEM Discover® microwave reactor) with gas cooling (pressure of 40 psi was maintained during irradiation) for 15 min at 40W with magnetic stirring, and a temperature limit of 60 ˚C (reaction time refers to the hold time at the desired set temperature). The reaction was diluted with methanol to homogenise and the reaction mixture was purified on automated flash column chromatography system (Biotage®) to give Boc-His(2-aryl)-ArgNHBzl/OMe. To a solution of N-α-Boc-2-aryl-L-His-OH (3a-g, 1 mmol), DIC (1.5 mmol), HONB (1.5 mmol) was added, and reaction mixture was microwave irradiated for 5 min. Benzylamine (1.5 mmol) was then added and the reaction mixture was allowed to stir at 60 o C for additional 25 min. The complete removal of solvent under reduced pressure produced crude product, which was purified on automated flash column chromatography system to afford N-
General method for the synthesis of 2-aryl-L-His-NHBzl (10a-g)
To a solution of N-α- 1mmol) was added 3N HCl (5 mL). The reaction mixture was allowed to stir at ambient temperature for 15 min resulting in the removal of the Boc group to give desired 2-aryl-L-His-NHBzl (10a-g).
General experimental procedure for dipeptides (11a-g and 15a-g)
In a 10 mL MW vial equipped with a magnetic stir bar, amino acid His(2-aryl)-NHBzl/OMe (1 mmol) were added followed by DIEA (3 mmol). Boc-Trp-OH (1.2 mmol) was added followed by DIC (1.2 mmol) and HONB (1.2 mmol). Mixture was subjected to MWirradiation (CEM Discover® microwave reactor) with gas cooling (pressure of 40 psi was maintained during irradiation) for 15 min at 40W with magnetic stirring, and a temperature limit of 60 ˚C (reaction time refers to the hold time at the desired set temperature). The reaction was diluted with methanol to homogenise and the reaction mixture was purified on automated flash column chromatography system (Biotage®) to give Boc-Trp-His(2-aryl)-NHBzl/OMe. 2
General experimental procedure for the synthesis of dipeptides (12a-g and 16a-g)
Boc-Trp-His(2-aryl)-NHBzl/OMe (1 mmol) upon reaction with 3N HCl (5 mL) at 25 ˚C for 15 min resulted in the removal of Boc group to give desired dipeptides.
General method of the synthesis of 2-aryl-L-histidine methyl esters·2HCl (14a-g)
To a mixture of 13a-g (1 mmol) in methanol (20 mL) was passed HCl gas for 2h at 4 o C. The solvent was removed to obtain 14a-g. 7, 171.3, 158.1, 155.9, 139.8, 136.3, 129.6, 128.5, 128.3, 117.3, 80.2, 55.6, 54.3, 44.1, 42.0, 30.4, 29.6, 28.7, 24 5, 173.6, 158.6, 147.8, 139.6, 131.0, 130.0, 129.6, 128.5, 128.3, 126.5, 80.9, 56.3, 54.3, 44.1, 42.0, 30.2, 28.7, 26.3 4, 173.7, 158.6, 148.0, 140.4, 139.6, 130.6, 129.6, 128.5, 128.3, 128.0, 126.5, 81.0, 56.2, 54.4, 44.1, 42.0, 30.4, 28.7, 26.3, 21.4 4, 173.6, 162.2, 158.6, 139.7, 129.6, 128.5, 128.1, 115.3, 81.1, 56.0, 54.8, 54.3, 44.1, 41.9, 30.2, 28.6, 26.4 4, 173.7, 158.6, 148.0, 140.4, 139.6, 130.6, 129.6, 128.5, 128.3, 128.0, 126.5, 56.2, 54.4, 44.1, 42.0, 30.4, 26.3, 21.4 4, 173.7, 162.1, 158.6, 139.6, 129.6, 128.5, 128.3, 128.2, 115.4, 56.1, 55.9, 54.9, 44.1, 42.0, 30.3, 26.3 4, 173.7, 158.6, 153.6, 139.6, 129.6, 128.5, 128.3, 126.9, 126.4, 56.2, 54.4, 44.1, 42.0, 35.6, 31.7, 30.2, 27.7, = 7.29 Hz, 1H), 7.66 (d, J = 8.53 Hz, 1H), 2H), 3H), 1H), 5H), 6.99 (s, 1H), 2H), 2H), 2H), 14 (m, 1H), 2.97-3.05 (m, 1H), 1.88-1.93 (m, 1H), 1.76-1.79 (m, 1H), 1.60-1.70 (m, 2H); 13 C NMR (CD 3 OD): 174. 5, 173.7, 158.6, 142.8, 141.5, 139.6, 130.0, 129.6, 128.8, 128.5, 128.3, 127.9, 127.0, 126.5, 54.9, 54.5, 44.1, 42.0, 30.3, 26.3 7.66 (d, J = 7.18 Hz, 1H), 2H), 3H), 2H), 2H), 2H), 2H), 3H), (m, 1H), 1.91-1.97 (m, 1H), 1.71-1.80 (m, 1H), 1.59-1.66 (m, 2H); 13 C NMR (CD 3 OD): δ 174. 5, 173.7, 158.6, 142.8, 141.5, 139.6, 130.0, 129.6, 128.8, 128.5, 128.3, 127.9, 127.0, 126.5, 54.9, 54.5, 44.1, 42.0, 30.3, 26.3 8, 173.5, 158.6, 136.2, 129.7, 80.9, 56.1, 53.3, 52.9, 41.8, 30.6, 29.8, 28.7, 26.0 6, 173.5, 158.6, 157.8, 131.1, 127.9, 126.9, 126.4, 80.8, 56.2, 53.1, 41.9, 30.7, 29.7, 28.7, 26 6, 173.5, 158.6, 157.7, 147.8, 140.4, 130.6, 128.1, 126.5, 80.8, 56.1, 54.9, 53.1, 41.9, 30.6, 29.7, 28.7, 26.2, 21.4 (m, 2H), 1.37 (s, 9H); 13 C NMR (CD 3 OD):  173. 5, 162.0, 158.6, 130.9, 128.1, 115.4, 80.8, 55.9, 54.3, 53.1, 41.9, 29.7, 28.7, 26 6, 173.5, 158.6, 140.4, 130.6, 126.5, 80.8, 56.1, 54.9, 53.1, 41.9, 30.6, 29.7, 28.7, 26.2, 31.4 6, 173.5, 158.6, 142.8, 141.5, 130.0, 129.9, 128.8, 128.5, 127.9, 126.9, 80.8, 56.1, 53.1, 41.9, 29.8, 28.7, 26 6, 173.6, 158.6, 157.8, 151.3, 147.3, 139.2, 135.4, 132.5, 130.6, 129.4, 128.4, 127.3, 126.9, 80.9, 54.9, 53.1, 41.9, 30.7, 29.7, 28.7, 26.2 6, 173.5, 158.6, 158.4, 136.2, 131.3, 117.9, 56.1, 53.1, 52.9, 41.9, 30.5, 29.8, 6, 173.5, 158.6, 157.8, 131.1, 127.9, 126.9, 126.4, 56.2, 53.1, 41.9, 30.7, 29.7, 26 6, 173.5, 158.6, 140.4, 130.6, 126.5, 56.1, 54.9, 53.1, 41.9, 30.6, 29.7, 26.2, 21.4 5, 162.0, 158.6, 130.9, 128.1, 115.4, 55.9, 54.3, 53.1, 41.9, 29.7, 26 13 C NMR (CD 3 OD):  174. 6, 173.5, 158.6, 140.4, 130.6, 126.5, 56.1, 54.9, 53.1, 41.9, 30.6, 29.7, 26.2, 31.4 6, 173.5, 158.6, 142.8, 141.5, 130.0, 129.9, 128.8, 128.5, 127.9, 126.9, 56.1, 53.1, 41.9, 29.8, 26.2 6, 173.6, 158.6, 157.8, 151.3, 147.3, 139.2, 135.4, 132.5, 130.6, 129.4, 128.4, 127.3, 126.9, 54.9, 53.1, 41.9, 30.7, 29.7, 7.59 (s, 1H), 5H), 6.82 (s, 1H), 2H), 1H), 3.01 (dd, J = 4.16, 8.04 Hz, 1H), 2.84 (dd, J = 4.26, 8.16 Hz, 1H) , 1.40 (s, 9H); 13 C NMR (CD 3 OD) :  172.9, 156.2, 138.3, 134.8, 134.1, 133.2, 128.1, 126.9, 126.7, 116.9, 79.3, 50.8, 44.3, 42.6, 29.3, 27.3 Hz, 1H), 7.68-7.77 (m, 1H), 7.44-7.50 (m, 3H), 7.21-7.31 (m, 5H), 7.01 (s, 1H), 4.41-4.45 (m, 2H), 4.32-4.35 (m, 1H), 3.14-3.19 (m, 1H), 2.95-3.01 (m, 1H) , 1.41 (s, 9H); 13 C NMR (CD 3 OD):  175. 6, 157.7, 139.7, 132.8, 130.2, 130.1, 129.5, 128.6, 128.4, 128.2, 126.4, 120.1, 80.7, 56.1, 44.1, 30.4, 28.7; = 7.91 Hz, 2H), 3H), 3H), 6.89 (s, 1H), 1H), 1H), 1H), 1H), 1H), 2.38 (s, 3H), 1.41 (s, 9H); 13 C NMR (CD 3 OD):  175. 6, 164.7, 157.7, 139.7, 130.6, 130.2, 130.1, 129.5, 128.6, 128.4, 128.2, 127.9, 126.6, 120.0, 80.9, 56.1, 44.1, 30.8, 28.7, 23.5 157.7, 139.7, 130.6, 130.2, 130.1, 129.5, 128.6, 128.4, 128.2, 127.9, 126.6, 120.1, 80.9, 56.1, 52.1, 44.1, 30.8, 28.7 = 7.27 Hz, 1H), 4H), 4H), 7.00 (s, 1H), 2H), 1H), 1H), 1H) , 1.41 (s, 9H), 1.13 (s, 9H); 13 C NMR (CD 3 OD):  174. 9, 157.8, 139.7, 130.6, 130.2, 130.1, 129.5, 128.6, 128.4, 128.2, 127.9, 126.6, 120.1, 80.9, 56.1, 44.2, 30.7, 30.2, 28.7, 28.4 Hz, 2H), 7.54 (br. s., 3H), 7.16-7.24 (m, 4H), 7.02-7. 10 (m, 5H), 7.00 (s, 1H), 4.27-4.36 (m, 2H), 4.19-4.26 (m, 1H), 3.22-3.28 (m, 1H), 3.02-3.07 (m, 1H) , 1.37 (s, 9H); 13 C NMR (CD 3 OD):  174. 9, 157.7, 139.7, 130.6, 130.2, 130.1, 129.5, 128.6, 128.4, 128.2, 127.9, 126.7, 125.5, 123.6, 117.8, 79.8, 56.1, 44.0, 30.1, 27.9 8, 157.3, 139.5, 130.7, 130.2, 130.1, 129.5, 129.1, 128.6, 128.4, 128.2, 127.9, 127.0, 126.6, 122.6, 119.4, 80.9, 57.6, 44.1, 30.8, 28.9 :  172.9, 138.3, 134.8, 134.1, 133.2, 128.1, 126.9, 126.7, 116.9, 55.0 , 50.8, 44.3, 42.6, 29.3 8, 132.8, 130.4, 130.2, 129.5, 128.7, 128.4, 128.2, 126.4, 120.1, 56.4, 44.5, 32.8 s., 1H), 3.18-3.28 (m, 1H), 2.93-3.02 (m, 1H), 2.14 (s, 3H); 13 C NMR (CD 3 OD):  175. 6, 164.9, 139.7, 130.6, 130.2, 130.0, 129.8, 128.6, 128.5, 128.4, 127.9, 126.6, 120.0, 56.4, 44.1, 30.8, 23.5 Hz, 1H), 7.32-7.39 (m, 3H), 7.08-7.16 (m, 5H), 6.99 (s, 1H), 4.27-4.36 (m, 2H), 4.20-4.25 (m, 1H), 3.78 (s, 3H), 3.22-3.31 (m, 1H), 2.97-3.07 (m, 1H); 13 C NMR (CD 3 OD):  175. 3, 139.9, 130.6, 130.5, 130.3, 129.5, 128.8, 128.4, 128.2, 127.9, 126.6, 120.3, 56.7, 52.4, 44.5, 32.9 7.32-7.40 (m, 4H), 7.09-7.18 (m, 4H), 7.02 (s, 1H), 4.28-4.37 (m, 2H), 4.21-4.26 (m, 1H), 3.30-3.32 (m, 1H), 3.25-3.29 (m, 1H) , 1.13 (s, 9H); 13 C NMR (CD 3 OD):  174. 8, 139.8, 130.6, 130.4, 130.2, 129.5, 128.8, 128.6, 128.4, 127.9, 126.6, 120.1, 56.1, 44.2, 31.8, 30.9, 28.6 
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